- Home
- SELF vs IMMX Comparison
SELF vs IMMX Comparison
Compare SELF & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SELF
- IMMX
- Stock Information
- Founded
- SELF 1983
- IMMX 2014
- Country
- SELF United States
- IMMX United States
- Employees
- SELF N/A
- IMMX N/A
- Industry
- SELF Real Estate Investment Trusts
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- SELF Real Estate
- IMMX Health Care
- Exchange
- SELF Nasdaq
- IMMX Nasdaq
- Market Cap
- SELF 60.1M
- IMMX 61.1M
- IPO Year
- SELF N/A
- IMMX 2021
- Fundamental
- Price
- SELF $5.28
- IMMX $2.71
- Analyst Decision
- SELF
- IMMX Strong Buy
- Analyst Count
- SELF 0
- IMMX 1
- Target Price
- SELF N/A
- IMMX $7.00
- AVG Volume (30 Days)
- SELF 31.1K
- IMMX 204.0K
- Earning Date
- SELF 08-08-2025
- IMMX 08-11-2025
- Dividend Yield
- SELF 5.49%
- IMMX N/A
- EPS Growth
- SELF 15.74
- IMMX N/A
- EPS
- SELF 0.22
- IMMX N/A
- Revenue
- SELF $12,622,544.00
- IMMX N/A
- Revenue This Year
- SELF N/A
- IMMX N/A
- Revenue Next Year
- SELF N/A
- IMMX N/A
- P/E Ratio
- SELF $24.01
- IMMX N/A
- Revenue Growth
- SELF 3.58
- IMMX N/A
- 52 Week Low
- SELF $4.70
- IMMX $1.26
- 52 Week High
- SELF $5.89
- IMMX $3.20
- Technical
- Relative Strength Index (RSI)
- SELF 42.61
- IMMX 53.07
- Support Level
- SELF $5.24
- IMMX $2.74
- Resistance Level
- SELF $5.50
- IMMX $3.20
- Average True Range (ATR)
- SELF 0.14
- IMMX 0.21
- MACD
- SELF -0.00
- IMMX -0.01
- Stochastic Oscillator
- SELF 19.05
- IMMX 23.44
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.